Advertisement
Screener

EPIZYME, INC. Patents: Active, 2019

EPIZYME, INC. Active Patents

9 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2019-12-02: Application 16618518; Invention USE OF EZH2 INHIBITORS FOR TREATING CANCER; Applicant Epizyme, Inc.; Status Patented Case.
  • 2019-10-22: Application 16660339; Invention ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS; Applicant Epizyme, Inc.; Status Patented Case.
  • 2019-10-22: Application 16660185; Invention METHOD FOR TREATING CANCER; Applicant Epizyme, Inc.; Status Patented Case.
  • 2019-10-21: Application 16606833; Invention COMBINATION THERAPIES WITH EHMT2 INHIBITORS; Applicant Epizyme, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2019-12-0216618518USE OF EZH2 INHIBITORS FOR TREATING CANCEREpizyme, Inc.Patented Case2023-03-1411602529US20200163945A1
Scott DAIGLE
Kat COSMOPOULOS
United States
United States
NORTHINGTON DAVIS, ZINNA
2019-10-2216660339ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDSEpizyme, Inc.Patented Case2021-07-0611052093US20200155562A1
Kevin W. KUNTZ
Richard CHESWORTH
Kenneth W. DUNCAN
Heike KEILHACK
Natalie WARHOLIC
Christine KLAUS
Sarah K. KNUTSON
Timothy J. N. WIGLE
Masashi SEKI
Syuji SHIROTORI
Satoshi KAWANO
United States
United States
United States
United States
United States
United States
United States
United States
Japan
Japan
Japan
GEMBEH, SHIRLEY V
2019-10-2216660185METHOD FOR TREATING CANCEREpizyme, Inc.Patented Case2021-01-2610898490US20200155561A1
Heike KEILHACK
Sarah K. KNUTSON
United States
United States
DAVIS, BRIAN J
2019-10-2116606833COMBINATION THERAPIES WITH EHMT2 INHIBITORSEpizyme, Inc.Patented Case2023-06-1311672800US20200054635A1
John Emmerson CAMPBELL
Kenneth William DUNCAN
Maria Alejandra RAIMONDI
Christine KLAUS
Elayne PENEBRE
United States
United States
United States
United States
United States
COPPINS, JANET L
2019-09-3016499476COMBINATION THERAPY FOR TREATING CANCEREpizyme, Inc.Patented Case2023-05-0911642346US20210100810A1
Christine KLAUS
Maria Alejandra RAIMONDI
United States
United States
XIAO, YAN
2019-07-0816504910PRMT5 INHIBITORS AND USES THEREOFEpizyme, Inc.Patented Case2021-04-2010980794US20200022973A1
Kenneth W. Duncan
Richard Chesworth
Paula Ann Boriack-Sjodin
Michael John Munchhof
Lei Jin
United States
United States
United States
United States
United States
REESE, HEIDI L
2019-06-1816444579METHOD FOR TREATING CANCEREpizyme, Inc.Patented Case2021-03-1610946024US20200009152A1
Heike KEILHACK
United States
WEDDINGTON, KEVIN E
2019-04-0216372657COMBINATION THERAPY FOR TREATING CANCEREpizyme, Inc.Patented Case2020-09-2910787440US20190315725A1
Heike KEILHACK
Sarah Kathleen KNUTSON
Kevin Wayne KUNTZ
United States
United States
United States
OLSON, ANDREA STEFFEL
2019-01-1116245986Isoxazole Carboxamides as Irreversible SMYD InhibitorsEPIZYME, INC.Patented Case2020-06-0210669243US20190241529A1
Richard Chesworth
Megan Alene Cloonan Foley
Kevin Wayne Kuntz
Lorna Helen Mitchell
Jennifer C. Petter
Carl Eric Schwartz
United States
United States
United States
United States
United States
United States
AGUIRRE, AMANDA L